- Home
- DPRO vs ONCY Comparison
DPRO vs ONCY Comparison
Compare DPRO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- ONCY
- Stock Information
- Founded
- DPRO 1998
- ONCY 1998
- Country
- DPRO Canada
- ONCY Canada
- Employees
- DPRO N/A
- ONCY N/A
- Industry
- DPRO Aerospace
- ONCY Pharmaceuticals and Biotechnology
- Sector
- DPRO Industrials
- ONCY Health Care
- Exchange
- DPRO Nasdaq
- ONCY Nasdaq
- Market Cap
- DPRO 81.2M
- ONCY 89.7M
- IPO Year
- DPRO N/A
- ONCY 1999
- Fundamental
- Price
- DPRO $4.90
- ONCY $1.03
- Analyst Decision
- DPRO Strong Buy
- ONCY Strong Buy
- Analyst Count
- DPRO 2
- ONCY 5
- Target Price
- DPRO $6.50
- ONCY $5.00
- AVG Volume (30 Days)
- DPRO 1.7M
- ONCY 681.0K
- Earning Date
- DPRO 08-11-2025
- ONCY 08-08-2025
- Dividend Yield
- DPRO N/A
- ONCY N/A
- EPS Growth
- DPRO N/A
- ONCY N/A
- EPS
- DPRO N/A
- ONCY N/A
- Revenue
- DPRO $5,250,872.00
- ONCY N/A
- Revenue This Year
- DPRO $69.58
- ONCY N/A
- Revenue Next Year
- DPRO $100.68
- ONCY N/A
- P/E Ratio
- DPRO N/A
- ONCY N/A
- Revenue Growth
- DPRO 17.08
- ONCY N/A
- 52 Week Low
- DPRO $1.55
- ONCY $0.33
- 52 Week High
- DPRO $7.31
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- DPRO 58.27
- ONCY 54.04
- Support Level
- DPRO $3.85
- ONCY $0.95
- Resistance Level
- DPRO $4.55
- ONCY $1.07
- Average True Range (ATR)
- DPRO 0.33
- ONCY 0.08
- MACD
- DPRO 0.04
- ONCY 0.01
- Stochastic Oscillator
- DPRO 91.55
- ONCY 81.89
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.